A 2018 trial of split dosing found steadier serum levels than single morning doses, per PubMed on split dosing
Currently, there is limited research on the long-term effects and safety of FMT in patients with atrial cardiomyopathy, underscoring the need for large-scale clinical trials to validate its sustained efficacy (231)
Gene expression profiling has shown significant differences between MMNST, melanoma, and schwannoma [13]
A complete PA submission typically includes: Patient demographics, current BMI with date of measurement, weight history showing chronicity, qualifying comorbidities with ICD-10 codes, documented prior weight-loss attempts and outcomes, prior pharmacotherapy trials and reasons for failure or intolerance, the prescriber's clinical rationale for the requested medication, and contraindications to alternative therapies if relevant